BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6893650)

  • 1. Decreased serum tuftsin concentrations in sickle cell disease.
    Spirer Z; Weisman Y; Zakuth V; Fridkin M; Bogair N
    Arch Dis Child; 1980 Jul; 55(7):566-7. PubMed ID: 6893650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased tuftsin concentrations in patients who have undergone splenectomy.
    Spirer Z; Zakuth V; Diamant S; Mondorf W; Stefanescu T; Stabinsky Y; Fridkin M
    Br Med J; 1977 Dec; 2(6102):1574-6. PubMed ID: 579324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of contaminants in commercial preparations of the tetrapeptide tuftsin by high-performance liquid chromatography.
    Amoscato AA; Babcock GF; Nishioka K
    J Chromatogr; 1981 Jan; 205(1):179-84. PubMed ID: 6894150
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin.
    Najjar VA
    J Pediatr; 1975 Dec; 87(6 Pt 2):1121-4. PubMed ID: 1242395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
    Najjar VA
    Klin Wochenschr; 1979 Aug; 57(15):751-6. PubMed ID: 385971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective phagocytosis due to tuftsin deficiency in splenectomized subjects.
    Constantopoulos A; Najjar VA; Wish JB; Necheles TH; Stolbach LL
    Am J Dis Child; 1973 May; 125(5):663-5. PubMed ID: 4512464
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuftsin and its analogues. III. Modification of basic amino acid residues in the peptide chain.
    Konopińska D; Nawrocka E; Siemion IZ; Szymaniec S; Slopek S
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):151-7. PubMed ID: 582100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired tuftsin deficiency.
    Spirer Z; Zakuth V; Orda R; Wiznitzer T; Mondorf W; Stefanescu T; Fridkin M
    Ann N Y Acad Sci; 1983; 419():220-6. PubMed ID: 6424535
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects.
    Spirer Z; Zakuth V; Bogair N; Fridkin M
    Eur J Immunol; 1977 Feb; 7(2):69-74. PubMed ID: 577481
    [No Abstract]   [Full Text] [Related]  

  • 11. Postsplenectomy splenic activity.
    Orda R; Barak J; Baron J; Spirer Z; Wiznitzer T
    Ann Surg; 1981 Dec; 194(6):771-4. PubMed ID: 7305494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA
    Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of splenic phagocytic function in Brazilian patients with sickle cell disease.
    Grotto HZ; Costa FF
    Rev Paul Med; 1992; 110(6):262-6. PubMed ID: 1341023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial sequences of histones with tuftsin activity.
    Konopínska D; Nawrocka E; Siemion IZ; Slopek S; Szymaniec S; Klonowska E
    Int J Pept Protein Res; 1977 Jan; 9(1):71-7. PubMed ID: 576424
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.
    Trevisani F; Castelli E; Foschi FG; Parazza M; Loggi E; Bertelli M; Melotti C; Domenicali M; Zoli G; Bernardi M
    Gut; 2002 May; 50(5):707-12. PubMed ID: 11950821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rigin, another phagocytosis-stimulating tetrapeptide isolated from human IgG. Confirmations of a hypothesis.
    Veretennikova NI; Chipens GI; Nikiforovich GV; Betinsh YR
    Int J Pept Protein Res; 1981 Apr; 17(4):430-5. PubMed ID: 7309346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes.
    Stabinsky Y; Gottlieb P; Zakuth V; Spirer Z; Fridkin M
    Biochem Biophys Res Commun; 1978 Jul; 83(2):599-606. PubMed ID: 581265
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of the Significance of Haemoglobin SS and SC in Disease Outcome in Patients With Sickle Cell Disease and Dengue Fever.
    Rankine-Mullings A; Reid ME; Moo Sang M; Richards-Dawson MA; Knight-Madden JM
    EBioMedicine; 2015 Aug; 2(8):937-41. PubMed ID: 26425701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical aspects of tuftsin deficiency syndrome.
    Najjar VA
    Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.